Plasma C3 and C5a predict increased intima-media thickness in patients with systemic lupus erythematosus (SLE) [52], and C5a predicts future cardiovascular events in patients with peripheral arterial disease [78], suggesting that complement activation contributes to progression of atherosclerosis and acute thrombotic events [79]. The gene discussed is C3; the disease is atherosclerosis.